[
  {
    "ts": null,
    "headline": "Why Charles River Laboratories (CRL) Stock Is Up Today",
    "summary": "Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target.",
    "url": "https://finnhub.io/api/news?id=4742bf682fc0e0bca5d398ec6445fc9ec05dd9d7a97c94bf0aabcd778ae28f9f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759419372,
      "headline": "Why Charles River Laboratories (CRL) Stock Is Up Today",
      "id": 136960785,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target.",
      "url": "https://finnhub.io/api/news?id=4742bf682fc0e0bca5d398ec6445fc9ec05dd9d7a97c94bf0aabcd778ae28f9f"
    }
  },
  {
    "ts": null,
    "headline": "Nike upgraded, RH downgraded: Wall Street's top analyst calls",
    "summary": "Nike upgraded, RH downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=8deb1001bce32c04740297ab6750ee40797079f66d64f044e9835449d4dd7bff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759412431,
      "headline": "Nike upgraded, RH downgraded: Wall Street's top analyst calls",
      "id": 136955886,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Nike upgraded, RH downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=8deb1001bce32c04740297ab6750ee40797079f66d64f044e9835449d4dd7bff"
    }
  },
  {
    "ts": null,
    "headline": "Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace",
    "summary": "Investing.com -- Barclays struck a more cautious but selective tone in its third-quarter U.S. life science tools and diagnostics preview, upgrading Charles River Laboratories while cutting Medpace.",
    "url": "https://finnhub.io/api/news?id=1e243ab9fcabe6347a659e1b0dfe87a0278a7d997ab557d6d0cddf4d843976d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759412066,
      "headline": "Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace",
      "id": 136956397,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Investing.com -- Barclays struck a more cautious but selective tone in its third-quarter U.S. life science tools and diagnostics preview, upgrading Charles River Laboratories while cutting Medpace.",
      "url": "https://finnhub.io/api/news?id=1e243ab9fcabe6347a659e1b0dfe87a0278a7d997ab557d6d0cddf4d843976d7"
    }
  },
  {
    "ts": null,
    "headline": "Barclays Upgrades Charles River Laboratories International (CRL)",
    "summary": "Barclays Upgrades Charles River Laboratories International (CRL)",
    "url": "https://finnhub.io/api/news?id=f3644a227266fa75c4019dfe626e1ccf8602157677216e77a86bfa5e3dd12d4e",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759406610,
      "headline": "Barclays Upgrades Charles River Laboratories International (CRL)",
      "id": 136954999,
      "image": "",
      "related": "CRL",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f3644a227266fa75c4019dfe626e1ccf8602157677216e77a86bfa5e3dd12d4e"
    }
  }
]